Literature DB >> 11502790

A "pheo" lurks: novel approaches for locating occult pheochromocytoma.

K Pacak1, D S Goldstein, J L Doppman, B L Shulkin, R Udelsman, G Eisenhofer.   

Abstract

Most, but not all, pheochromocytomas can be localized by computed tomography or magnetic resonance imaging. Here we introduce two novel approaches for localization of pheochromocytoma in a patient in whom conventional imaging modalities failed to show the tumor. First, we establish that measurements of plasma free metanephrines coupled with vena caval sampling are useful for localizing occult pheochromocytoma, particularly when elevations in plasma catecholamines are slight or intermittent. Second, we show that positron emission tomographic scanning using the imaging agent 6-[18F]fluorodopamine as a substrate for the norepinephrine transporter offers a highly effective method for tumor localization. These novel approaches may be of value in difficult cases, where biochemical and clinical evidence of pheochromocytoma is compelling, yet conventional imaging modalities fail to locate the tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502790     DOI: 10.1210/jcem.86.8.7714

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

2.  Adrenal venous catecholamine concentrations in patients with adrenal masses other than pheochromocytoma.

Authors:  Yasutaka Baba; Masayuki Nakajo; Sadao Hayashi
Journal:  Endocrine       Date:  2012-09-13       Impact factor: 3.633

3.  Efficient automated syntheses of high specific activity 6-[18F]fluorodopamine using a diaryliodonium salt precursor.

Authors:  Kiel D Neumann; Linlin Qin; Amy L Vāvere; Bin Shen; Zheng Miao; Frederick T Chin; Barry L Shulkin; Scott E Snyder; Stephen G DiMagno
Journal:  J Labelled Comp Radiopharm       Date:  2015-12-23       Impact factor: 1.921

4.  Is there still a place for adrenal venous sampling in the diagnostic localization of pheochromocytoma?

Authors:  Roland Därr; Graeme Eisenhofer; Jörg Kotzerke; Klaus Zöphel; Christian Stroszczynski; Jaap Deinum; Leo J Schultze Kool; Steffen Pistorius; Hartmut Neumann; Stefan R Bornstein; Lorenz C Hofbauer
Journal:  Endocrine       Date:  2011-04-21       Impact factor: 3.633

5.  A patient with a large recurrent pheochromocytoma demonstrating the pitfalls of diagnosis.

Authors:  Jörg Singer; Christian A Koch; Woubet Kassahun; Peter Lamesch; Graeme Eisenhofer; Regine Kluge; Thomas Lincke; Matthias Seiwerts; Gudrun Borte; Katrin Schierle; Ralf Paschke
Journal:  Nat Rev Endocrinol       Date:  2011-09-06       Impact factor: 43.330

6.  Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.

Authors:  Henri J L M Timmers; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Alexander Ling; Bastiaan Havekes; Graeme Eisenhofer; Lucia Martiniova; Karen T Adams; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2009-10-28       Impact factor: 5.958

7.  Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma.

Authors:  Ioannis Ilias; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Alexander Ling; Ivica Lazúrová; Karen T Adams; Shiromi Perera; Karel Pacak
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

Review 8.  Adrenal tumors: how to establish malignancy ?

Authors:  M Fassnacht; W Kenn; B Allolio
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

Review 9.  New imaging approaches to phaeochromocytomas and paragangliomas.

Authors:  Bas Havekes; Kathryn King; Edwin W Lai; Johannes A Romijn; Eleonora P M Corssmit; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2009-06-08       Impact factor: 3.478

Review 10.  Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.

Authors:  Graeme Eisenhofer; David S Goldstein; Irwin J Kopin; J Richard Crout
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.